An Israeli study found that a fourth dose of the Pfizer COVID-19 vaccine doesn’t offer long-lived protection against the Omicron variant of the CCP virus.
Using Ministry of Health data on more than 1.2 million people, researchers found that a second booster dose of the BioNTech-Pfizer vaccine offered protection against significant COVID-19 infections for six weeks. But protection against all virus infections started to drop quickly after four weeks and nearly disappeared after eight weeks …
Several weeks ago, Israeli researchers found in a separate preprint study that the protection from a second Pfizer booster quickly diminished. Protection against infection rose initially after the fourth dose, reaching 64 percent during the third week, but it rapidly declined to 29 percent by 10 weeks, they found.
“It appears that effectiveness of the fourth dose wanes sooner, similarly to the fact that the third dose wanes sooner than the second dose,” the study said.
Decreasing protection with each booster. And perhaps increased damage to your general immune system. There are some bad possibilities.